Balance Sheets (USD $)	Jan. 31, 2014	Jul. 31, 2013
Current assets
Cash and cash equivalents	$ 420,428	$ 598,623
Prepaid insurance	4,250	21,250
Total current assets	424,678	619,873
Other assets
Patents and patent applications (net of accumulated amortizaton of $4,956 at January 31, 2014 and $4,270 at July 31, 2013)	22,494	23,180
Total assets	447,172	643,053
Current liabilities
Accounts payable and accrued liabilities	13,052	40,767
Accrued salaries and wages	782,474	457,636
Due to related party	350,000	350,000
Convertible notes payable, net of debt discounts		25,000
Derivative liability		9,666
Total current liabilities	1,145,526	883,069
Deferred revenue	1,003,500	750,000
Total liabilities	2,149,026	1,633,069
Stockholders' deficit
Common stock; par value $0.001; 200,000,000 shares authorized; 178,206,053 shares issued and outstanding at January 31, 2014 and 164,699,973 shares issued and outstanding at July 31, 2013	178,205	164,700
Additional paid-in capital	39,739,282	33,695,679
Accumulated deficit during the development stage	(41,619,341)	(34,850,395)
Total stockholders' deficit	(1,701,854)	(990,016)
Total liabilities and stockholders' deficit	$ 447,172	$ 643,053